c-Jun NH2-terminal Kinase Regulation of the Apoptotic Response of Small Cell Lung Cancer Cells to Ultraviolet Radiation*

(Received for publication, October 16, 1996, and in revised form, February 3, 1997)

Laura Butterfield , Brooke Storey , Lara Maas and Lynn E. Heasley Dagger

From the Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES


ABSTRACT

Exposure of cultured small cell lung cancer (SCLC) cells to UV radiation induces apoptosis. We observed that the UV sensitivity of a panel of SCLC lines and the activation of c-Jun NH2-terminal kinases (JNKs) by UV in the individual SCLC lines, assessed by binding and phosphorylation of glutathione S-transferase (GST)-c-Jun fusion proteins, ranged widely. In fact, increased JNK activity in this assay was closely correlated with decreased sensitivity to apoptosis following UV irradiation. Increased JNK activity was also detected in anti-JNK1 immune complexes collected from UV-irradiated SCLC cells, although the level of activity was similar among the various SCLC lines and correlated poorly with UV sensitivity. Immunoblot analysis of JNK polypeptides that bound to GST-c-Jun revealed at least two JNK polypeptides, one of which appeared only in extracts from UV-irradiated SCLC. To test the role of JNKs in UV-induced apoptosis, nonphosphorylatable mutants of JNK1 or JNK2 in which the phosphorylation site Thr-Pro-Tyr is changed to Ala-Pro-Phe (JNK-APF) and are predicted to behave as competitive inhibitors were stably expressed in SCLC. Expression of JNK1-APF or JNK2-APF significantly reduced UV-stimulated JNK activity. However, JNK1-APF markedly increased the resistance of the cells to UV-induced apoptosis, while JNK2-APF did not influence SCLC sensitivity to UV. The findings suggest that UV-stimulated JNK1 activation promotes UV-induced SCLC apoptosis, while a JNK isoform that is variably activated among the SCLC lines may signal a UV-protective response. We hypothesize that integration of distinct JNK activities dictates the relative responsiveness of SCLC to UV and ionizing radiation.


INTRODUCTION

Small cell lung cancer (SCLC)1 is a rapidly growing human cancer that accounts for approximately 25% of primary lung cancers. Compared with the majority of non-small cell lung cancers, SCLC exhibits neuroendocrine features (1) and is characteristically more sensitive to ionizing radiation and cytotoxic drugs (2-4). Emerging evidence suggests that the sensitivity of tumor cells such as SCLC to ionizing radiation and cytotoxic drugs is not related to their rapid rate of cell division, but to the ability of these cell stresses to induce programmed cell death, or apoptosis, relative to growth arrest of untransformed cells (5). However, as with many cancers, selection for SCLC tumor cells that are relatively resistant to the cytotoxic insult frequently occurs and is followed by relapse, translating to a cure rate of 10% or less. Cell lines derived from relapsed SCLC tumors often exhibit the variant phenotype (1, 6-8) associated with loss of neuroendocrine differentiation, gene amplification of the Myc family members, and increased growth rates in vitro. This general problem emphasizes the importance of defining both the mechanism of radiation and cytotoxic drug-induced tumor cell death as well as the molecular mechanisms accounting for cellular resistance.

Recent advances in the understanding of cellular responses to cytotoxic stresses such as ionizing and UV radiation, tumor necrosis factor-alpha , heat shock, and toxic drugs have defined the regulation of a protein kinase signaling cascade that targets specific transcription factors including c-Jun, c-Fos, ATF-2, and NFkappa B (9-15). UV irradiation is the prototypical activator of this highly conserved cellular pathway referred to as the UV response (16). Transactivation of genes by c-Jun and ATF-2 is achieved by phosphorylation by specific mitogen-activated protein (MAP) kinase family members, the stress-activated protein kinases (SAPKs), or c-Jun NH2-terminal kinases (JNKs) (12-14, 17-19). Molecular cloning has defined three genes encoding rodent SAPK or human JNK enzymes, and alternative splicing of the mRNAs yields as many as 12 distinct enzymes (19-22). In a manner parallel to that previously defined for the related extracellular signal-regulated kinases (ERKs) or p42/44 MAP kinases (23), the JNKs are activated following their phosphorylation on threonine and tyrosine by dual specificity MAP kinase kinases (24). While DNA damage is often a consequence of exposure to agents that stimulate the UV response, the regulation of JNKs and NFkappa B proceeds normally in enucleated cells (11), indicating that DNA damage is not the initiating signal. In fact, the Ras and Rho families of low molecular weight GTP-binding proteins, which integrate signaling via a host of extracellular signals, play a role in mediating the UV response in mammalian cells and yeast (11, 16). This finding further supports the notion that the UV-induced transcriptional activation through JNK protein kinase cascades is independent of DNA damage and is probably initiated at the plasma membrane.

Studies suggest that the UV response serves a protective role in lower organisms such as yeasts (16). Yet, the functional significance of the UV response in mammalian cells is unclear. Ras-transformed mammalian cells are often more resistant to UV and ionizing radiation (25, 26). However, the profound and rapid activation of JNKs by many cytotoxic stimuli suggests that the JNKs may, in fact, initiate cell death in mammalian cells rather than a protective response. Support for this possibility is provided by findings that MAP kinase/ERK kinase kinase, which has recently been defined as a proximal activator of the JNK pathway (27), can induce apoptosis when expressed in fibroblast cell lines (28), and cellular expression of molecular inhibitors of the JNK pathway reduces the induction of apoptosis (29, 30). To investigate the role of the JNK pathway in SCLC, we examined the influence of UV irradiation on induction of cell death and signal transduction through JNKs in a panel of cultured SCLC lines.


EXPERIMENTAL PROCEDURES

Materials

Recombinant GST-c-Jun(1-79) and ATF2-NT(1-254) were expressed in bacteria and purified using glutathione agarose (Sigma) and Ni+-nitrilotriacetic acid-agarose (Qiagen, Studio City, CA), respectively, as described previously (17, 31). Sera and powdered growth media were from Life Technologies, Inc. The rabbit polyclonal antibodies to JNK-1 (C-17), p38 MAP kinase (C-20), ERK1 (C-16), and ERK2 (C-14) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The mouse monoclonal antibody directed against the influenza hemagglutinin (HA) epitope (12CA5), dUTP-fluorescein, and terminal deoxytransferase were from Boehringer Mannheim. Protein A- and protein G-Sepharose were purchased from Pharmacia Biotech Inc.

Cell Culture and Retrovirus-mediated Gene Transfection

NCI-H345 and H187 cells were cultured in HITES medium (RPMI 1640 containing 10 nM hydrocortisone, 5 µg/ml insulin, 10 µg/ml transferrin, 10 nM 17beta -estradiol, 30 nM sodium selenite, and 0.1% bovine serum albumin). SCLC lines N417, SHP-77, and H69 were routinely cultured in RPMI 1640 containing 10% fetal bovine serum. Cell lines H69, H187, and H345 exhibit features of classic SCLC (1), whereas N417 is a variant SCLC line (1, 6), and SHP-77 exhibits features of both classic and variant SCLC. Swiss 3T3 fibroblasts were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum.

For experiments examining the influence of UV irradiation on cell growth and signaling, suspensions (2 ml) of SCLC cells in HITES medium were placed in 6-cm plastic tissue culture plates and irradiated uncovered with a Mineralight R-52G (UVP, Inc., San Gabriel, CA) short wave UV lamp. The radiance of the lamp at 254 ± 20 nm at a distance of 2 inches was 3.2 J/m2/s. Following irradiation, the cells were incubated at 37 °C for the indicated times in a CO2 incubator. For determination of cell counts, SCLC cell suspensions were mixed with an equal volume of 0.4% trypan blue in 0.85% NaCl, and cells excluding dye were counted with a hemocytometer. Swiss 3T3 cells were similarly counted after trypsinization.

The cDNAs (18, 32, 33) encoding HA-JNK1-APF and HA-JNK2-APF were ligated between the HindIII and HpaI sites of pLNCX (34) and packaged into replication-defective retrovirus using 293T cells and the retrovirus component-expression plasmids SV-Psi --A-MLV and SV-Psi --env--MLV as described previously (35, 36). Conditioned growth medium containing secreted retrovirus was collected, supplemented with 8 µg/ml polybrene, filtered through a 0.45-µm filter, and incubated with the indicated SCLC lines for 24 h. SCLC cells expressing the retrovirus-encoded cDNAs were selected for growth in medium containing G418, and pooled cultures of G418-resistant cells were used for the described studies.

Determination of Apoptosis

Terminal Deoxytransferase Labeling

Following UV irradiation (96 J/m2) as described above, the SCLC cultures were returned to the CO2 incubator for 24 h. Aliquots (1.5 ml) of control and irradiated cultures of SCLC were centrifuged (500 × g, 5 min) and washed once in phosphate-buffered saline (PBS). The cells were fixed for 15 min in PBS containing 1.5% paraformaldehyde and 1.5% sucrose and then washed with 1 ml of PBS and then with 250 µl of terminal deoxytransferase buffer (25 mM Tris-Cl (pH 6.6 at 25 °C), 200 mM potassium cacodylate, 0.25 mg/ml bovine serum albumin). The cell pellets were finally suspended in 50 µl of terminal deoxytransferase buffer containing 1.5 mM CoCl2, 3 µM fluorescein-dUTP, and 5 units of terminal deoxytransferase and incubated for 2 h at 37 °C. The reactions were terminated by the addition of 20 mM EDTA and the labeled cells were collected by centrifugation, washed once with PBS, and resuspended in 50 µl of PBS. The cells were immobilized onto coverslips precoated with Cell-Tak (Collaborative Biomedical Products, Bedford, MA) and viewed at × 60 magnification with a fluorescence microscope.

Propidium Iodide Staining

Twenty-four and forty-eight hours later, aliquots of control and UV-irradiated cultures containing ~200,000 cells were centrifuged (5 min, 1000 × g), and the cell pellets were gently suspended in 100 µl of PBS. The cells were fixed by addition of 400 µl of methanol and stained for 15 min with propidium iodide (50 µg/ml). The cells were again collected by centrifugation, suspended in PBS containing 50% glycerol, and mounted under glass coverslips. Slides were viewed and photographed on a fluorescence microscope.

Assay of JNK Activity

GST-c-Jun(1-79) Binding/Protein Kinase Assay

SCLC cells were collected by centrifugation and lysed for 30 min at 4 °C in 0.5 ml of 25 mM HEPES (pH 7.7), 20 mM beta -glycerophosphate, 0.1 mM sodium vanadate, 0.1% Triton X-100, 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, 2 µg/ml leupeptin, and 4 µg/ml aprotinin as described elsewhere (17). Following a 5-min microcentrifugation (10,000 × g), aliquots of the extracts containing 200 µg of protein were incubated for 2 h at 4 °C with GST-c-Jun(1-79) immobilized to glutathione-agarose (10 µl of packed beads per sample containing ~10 µg of protein). The GST-c-Jun(1-79)-agarose complexes were washed three times by repetitive centrifugation in 20 mM HEPES (pH 7.7), 50 mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.05% Triton X-100, and then incubated for 20 min at 30 °C in 40 µl of 50 mM beta -glycerophosphate (pH 7.6), 0.1 mM sodium vanadate, 10 mM MgCl2, 20 µM [gamma -32P]ATP (25,000 cpm/pmol). The reactions were terminated with 10 µl of SDS-PAGE sample buffer, boiled, and submitted to 12% SDS-PAGE. The GST-c-Jun(1-79) polypeptides were identified in Coomassie-stained gels, excised, and counted in a scintillation counter.

Immune Complex JNK and p38 MAP Kinase Assay

SCLC cultures were collected by centrifugation and lysed in MAP kinase lysis buffer (0.5% Triton X-100, 50 mM beta -glycerophosphate (pH 7.2), 0.1 mM sodium vanadate, 2 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol, 2 µg/ml leupeptin, and 4 µg/ml aprotinin). Clarified extracts containing 200 µg of protein were incubated (4 °C, 2 h) with 1 µg of anti-JNK1, 1 µg of anti-p38 MAP kinase, or 1 µg each of anti-ERK1 and anti-ERK2 and 10 µl of packed protein A-Sepharose in a total volume of 0.5 ml. The immune complexes were washed three times in lysis buffer and then suspended in 40 µl of 50 mM beta -glycerophosphate (pH 7.2), 0.1 mM sodium vanadate, 10 mM MgCl2, 100 µM [gamma -32P]ATP (5000 cpm/pmol), 25 µg/ml IP-20 (TTYADFIASGRTGRRNAIHD), 1 mM EGTA, and either 100 µg/ml ATF2-NT, an excellent substrate for JNKs and p38 MAP kinase (12), or 200 µM EGFR662-681 peptide for analysis of ERK activity (37). Following a 20-min incubation at 30 °C, the ATF2 kinase reactions were terminated with 10 µl of SDS sample buffer and submitted to SDS-PAGE. The ATF2 polypeptides were excised from the Coomassie-stained and dried gels, and incorporated radioactivity was determined in a scintillation counter. The EGFR662-681 peptide kinase reactions were terminated with 10 µl of 25% trichloroacetic acid, and phosphorylated peptide was quantified by P81 binding as described previously (37).

Immunoblot Analyses

Samples were resolved by 10% SDS-PAGE and transferred to nitrocellulose. The filters were blocked in Tris-buffered saline (10 mM Tris-Cl (pH 7.4), 140 mM NaCl) containing 0.1% Tween-20 (TTBS) and 3% nonfat dry milk and then incubated with blocking solution containing the indicated antibodies at 1 µg/ml for 12-16 h. The filters were extensively washed in TTBS, and bound antibodies were visualized with horseradish peroxidase-coupled protein A or horseradish peroxidase-coupled sheep anti-mouse antibodies and ECL (Amersham Corp.) according to the manufacturer's directions.


RESULTS

Variable Induction of SCLC Apoptosis following UV Irradiation

The radiosensitivity of SCLC is well established, and the survival of a variety of SCLC lines following ionizing radiation has been previously compared (2, 4). The growth and viability of control SCLC line H345 or cultures irradiated with a UV-C (200 to 290 nM) source at intensities of 32 or 192 J/m2 is shown in Fig. 1A. After 4 days in culture, the density of control H345 cultures increased 3-fold, while cultures of H345 cells UV-irradiated at 32 J/m2 failed to grow. In fact, cell number decreased slightly, suggesting limited cell death. UV irradiation of H345 cells at 192 J/m2 resulted, after a lag of approximately 24 h, in a progressive and marked decrease in cell number below the initial cell density, such that less than 5% of the irradiated cells were viable as assessed by trypan blue exclusion after 4 days of culture.


Fig. 1. UV irradiation induces cell death in SCLC lines. A, control suspensions of SCLC line H345 or suspensions of cells UV irradiated at 32 or 192 J/m2 were cultured for the indicated times, and viable cells were determined by trypan blue exclusion. B, suspensions of the SCLC cell lines were irradiated at the indicated dose as described under "Experimental Procedures," and the number of viable cells was determined by trypan blue exclusion 4 days later. The data in panel A are from a single experiment representative of two other independent experiments, and the data in panel B are the means ± S.E. of three to five experiments.
[View Larger Version of this Image (19K GIF file)]


Examination of the dose dependence of UV-induced cell killing of five independent SCLC lines and Swiss 3T3 fibroblasts was performed (Fig. 1B). UV irradiation at intensities ranging from 6 to 192 J/m2 resulted in a dose-dependent decrease in viable cells measured 4 days later compared with untreated controls in all the cell lines tested. Notably, the SCLC lines were more sensitive to UV-induced cell killing than Swiss 3T3 fibroblasts at UV intensities of 16-64 J/m2, consistent with the known sensitivity of SCLC to ionizing radiation (2-4). Among the SCLC lines, H187 was the most sensitive to UV-induced killing such that less than 50% of the cells survived the lowest UV intensity tested, 6 J/m2 (Fig. 1B). H69 was somewhat more resistant and H345 cells were significantly more resistant to UV-C-induced killing than were H187 cells, but were still highly sensitive compared with cell lines SHP-77 and N417. H187, H69, and H345 cells exhibit features of classic SCLC, while SHP-77 and N417 cells express elevated c-Myc and/or lack of detectable neuropeptide autocrine loops, features indicative of the variant SCLC phenotype (1). Significantly, H69, H187, H345, and N417 have been previously examined for sensitivity to ionizing radiation, and a similar order of sensitivity to ionizing radiation was observed (2, 4).

The time-dependent decrease in viable cell number following UV irradiation was suggestive of apoptosis, which is defined as cell death that is physiologically regulated and is characterized morphologically by DNA breakage and nuclear condensation (38). Induction of DNA breaks following UV was assessed by terminal deoxytransferase-mediated labeling of nuclei with fluorescein-dUTP (Fig. 2). The terminal deoxytransferase assay resulted in the labeling of ~1-5% of a control untreated suspension of H345 cells, while ~50% of H345 cells were labeled when assayed 24 h after UV irradiation (96 J/m2). Pronounced condensation of chromatin, another feature of apoptosis, was assessed by microscopic inspection of UV-irradiated SCLC lines H187 and N417 that had been fixed and then stained with the DNA dye, propidium iodide. The results from these experiments revealed marked nuclear condensation that was apparent 24 h after UV irradiation (Fig. 3). Forty-eight hours after exposure to UV radiation (96 J/m2), greater than 95% of the H187 cell nuclei were highly condensed relative to the nuclei observed in untreated control cells. Compared with H187 cells, fewer N417 cells (~50%) exhibited condensed nuclei 2 days after UV irradiation, consistent with the decreased sensitivity of N417 cells to UV-induced cell death shown in Fig. 1B. Thus, the data indicate that UV irradiation induces cell death of five independent SCLC lines with variable efficacy and that the response occurs by apoptosis.


Fig. 2. Terminal deoxytransferase-mediated labeling of UV-irradiated SCLC. Control suspensions of SCLC H345 cells or cells previously (24 h) exposed to UV (96 J/m2) were collected and submitted to terminal deoxytransferase-mediated incorporation of fluorescein-dUTP as described under "Experimental Procedures." Fields of control H345 cells contained 1-5% apoptotic cells, while field of UV-irradiated cells at similar densities contained approximately 50% apoptotic cells.
[View Larger Version of this Image (55K GIF file)]



Fig. 3. Nuclear condensation in UV-irradiated SCLC cells. SCLC lines H187 and N417 were UV-irradiated (96 J/m2), and 24 and 48 h later, cells were fixed, stained with propidium iodide, and photographed with a fluorescence microscope as described under "Experimental Procedures." Note the progressive appearance of cells with highly condensed nuclei 24 and 48 h after irradiation. The experiment shown is representative of three independent experiments.
[View Larger Version of this Image (54K GIF file)]


Detection of Multiple UV-regulated JNK Activities in SCLC

An understanding of the molecular regulation of the JNK/SAPKs initiated by cell stresses such as UV radiation has recently emerged. To examine the regulation of JNKs by UV in the panel of SCLC lines, an assay was employed in which the JNKs are adsorbed to a glutathione agarose-immobilized GST fusion protein encoding the NH2-terminal 79 amino acids of the transcription factor c-Jun and then assayed for phosphotransferase activity toward the resident GST-c-Jun(1-79) polypeptide (17). Preliminary experiments in which H345 cells were UV-irradiated at 96 J/m2 indicated that protein kinase activity collected with GST-c-Jun(1-79) increased rapidly following irradiation and was maximal by 10- 30 min of incubation following the UV exposure. Furthermore, this JNK activity was sustained for at least 2 h, the longest time point examined.

The UV dose response for activation of the GST-c-Jun-binding JNKs was determined in the five SCLC lines (Fig. 4A). SCLC lines H187 and H69, which are the most sensitive to UV-induced cell death (Fig. 1B), exhibited a modest 2-4-fold activation of protein kinase activity at a UV dose of 192 J/m2. In comparison, N417 and SHP-77, which are the most UV-resistant of the SCLC lines, exhibited marked UV-stimulated GST-c-Jun kinase activity. Note that a 5-10-fold activation was observed with N417 at a UV intensity of only 16 J/m2. Finally, H345 cells, which are of intermediate sensitivity to UV irradiation (Fig. 1B), exhibited an intermediate UV-stimulated JNK activation. When the UV-induced GST-c-Jun kinase activation observed at 64 J/m2 (Fig. 4A) was compared with the fraction of cells surviving the same UV dose (Fig. 1B), an excellent correlation was observed (r2 = 0.93, slope very significantly (p < 0.01) different from zero). Thus, the data in Figs. 1B and 4A reveal that the fold stimulation of a UV-regulated, GST-c-Jun-binding protein kinase activity correlates with the relative resistance of the SCLC lines to UV-induced cell death.


Fig. 4. Increased GST-c-Jun-associated JNK activity correlates with increased resistance of SCLC to UV-induced cell death. A, suspensions of the SCLC lines were irradiated at the indicated UV-C doses and then incubated for 30 min at 37 °C. Extracts were prepared and assayed for JNK activity with the GST-c-Jun binding assay as described under "Experimental Procedures." B, extracts were prepared from control and UV-irradiated (96 J/m2) suspensions of the indicated SCLC lines and assayed for JNK activity with the anti-JNK immunecomplex assay (see "Experimental Procedures").
[View Larger Version of this Image (26K GIF file)]


A polyclonal antiserum directed against the C terminus of the p46 JNK1 isoform was also used to measure the UV-regulated protein kinase activity in an immune complex assay. The findings (Fig. 4B) revealed a 3-8-fold stimulation of immune complex-associated protein kinase activity by UV in extracts prepared from the panel of SCLC lines. Similar analysis of ERK and p38 MAP kinases immunoprecipitated from extracts prepared from control and UV-irradiated H345 and SHP-77 cells revealed a 3.8- and 2-fold stimulation of ERKs, respectively, and a 1.1- and 2.8-fold stimulation of p38 MAP kinase, respectively. Thus, the ERK and p38 MAP kinases displayed little or no regulation by UV in SCLC, despite reports of strong regulation of p38 MAP kinase by UV in other cell types (39). Note that the fold stimulation by UV (96 J/m2) of anti-JNK1-precipitated protein kinase activity from H345, N417, and SHP-77 cells was significantly less than that observed in the GST-c-Jun complex assay (Fig. 4A). Also, the fold stimulations observed with the immune complex assay did not correlate with the relative resistance to UV-induced cell death (r2 = 0.04, slope is not significantly different from zero). The different fold stimulations observed with the GST-c-Jun and immune complex assays in the various SCLC lines suggests that distinct populations of cellular JNK enzymes were measured. The sequence of the JNK1 peptide to which the commercial JNK1 antibody was generated is 100, 70, 59, 41, 82, and 53% identical to the sequences (20, 22) of rodent SAPK p46gamma , p54gamma , p46alpha , p54alpha , p46beta , and p54beta , respectively. The human homologues of SAPK alpha , beta , and gamma  are JNK1, JNK3, and JNK2. Thus, the antibody would be predicted to exhibit a selectivity of p46 JNK1 > p46 JNK3 > p54 JNK1 > p46 JNK2 > p54 JNK3 > p54 JNK2. Immunoblot analysis of SCLC cells expressing exogenous JNK1 and JNK2 molecules (not shown) with the JNK1 antibody readily detected the JNK1 polypeptide, but not the JNK2 polypeptide, supporting the predicted specificity of this antibody.

To further characterize the UV-stimulated JNK activity that bound to GST-c-Jun and correlated with increased resistance to UV-induced apoptosis, SCLC proteins were adsorbed to GST-c-Jun beads, resolved by SDS-PAGE, and immunoblotted with the polyclonal JNK1 antibody. The results (Fig. 5) revealed detectable JNK immunoreactivity with an estimated mass of 46 kDa that was specifically retained by GST-c-Jun, but not GST, from extracts prepared from unirradiated H69, SHP-77, and N417 cells. Note, however, that the majority of JNK immunoreactivity remained in the unbound fractions. These cell lines exhibit similar UV-induced JNK activity with the JNK1 immunoprecipitation reactions, but SHP-77 and N417 cells exhibit a much greater UV-stimulated JNK response with the GST-c-Jun-binding assay (Fig. 4). Similar analysis of extracts from UV-irradiated H69, SHP-77, and N417 cells revealed the appearance in SHP-77 and N417 extracts, but not H69 extracts, of a more slowly migrating species at ~48-50 kDa that specifically bound to GST-c-Jun and was largely depleted from the unbound fraction (compare GST- and GST-c-Jun-bound and -unbound fractions from UV-treated cells in Fig. 5). The low level of p46-kDa JNK binding to GST-c-Jun was not different between extracts from control and UV-irradiated cells. Thus, these data are consistent with the specific binding of at least two populations of JNK enzymes by GST-c-Jun. These activities are represented by the p46-kDa immunoreactivity that binds equally from control and activated extracts and the p48-50-kDa species that appears in extracts from UV-irradiated cells and is largely captured by GST-c-Jun. The observed tendency of MAP kinases to migrate more slowly on SDS-PAGE following phosphorylation and activation indicates that the more slowly migrating JNK immunoreactivity is possibly a phosphorylated and activated JNK isoform.


Fig. 5. Detection of JNK polypeptides in SCLC extracts that associate with GST-c-Jun. Suspensions of control and UV-irradiated (96 J/m2) H69, SHP-77, and N417 cells were incubated for 30 min at 37 °C, collected by centrifugation, and lysed in MAP kinase lysis buffer as described under "Experimental Procedures." Portions of the extracts (200 µg of protein) were incubated with GST-agarose or GST-c-Jun(1-79)-agarose for 2 h at 4 °C. The agarose beads with bound (B) cellular polypeptides were collected by centrifugation, and the supernatant polypeptides containing free (F) JNKs were supplemented with concentrated SDS-PAGE sample buffer. The agarose bead-conjugates were washed three times with MAP kinase buffer and dissolved in SDS sample buffer, and both bound (B) and free (F) samples were submitted to SDS-PAGE and immunoblotting with the polyclonal JNK1 antibody.
[View Larger Version of this Image (40K GIF file)]


Influence of Expression of Inhibitory JNK Mutants on JNK Activation and Induction of SCLC Apoptosis

The findings in Figs. 4 and 5 support the existence of distinct JNK isoforms that are activated following UV irradiation of SCLC. To test the role of JNKs in UV-induced SCLC apoptosis, we stably expressed influenza hemagglutinin epitope-tagged JNK1 and JNK2 mutants in which the phosphorylated threonine and tyrosine in the TPY phosphorylation motif are changed to alanine and phenylalanine, producing a nonphosphorylatable, competitive-inhibitory JNK-APF. Transient expression of these JNK-APF mutants has been previously shown to inhibit JNK-mediated transcriptional regulation (32, 40). Fig. 6A shows an immunoblot of cell extracts from SHP-77 cells in which the HA-JNK1-APF and HA-JNK2-APF cDNAs were transduced by the indicated retroviruses. A similar level of expression of the two HA-tagged polypeptides was noted. JNK1-APF expression reduced UV-stimulated JNK activation to 31 and 36% of the LNCX control response using the JNK immune complex and GST-c-Jun binding assays, respectively (Fig. 6B). Likewise, JNK2-APF inhibited JNK activation to 51 and 39% of the LNCX response as defined with the JNK immune complex and GST-c-Jun assays, respectively (Fig. 6B).


Fig. 6. Stable expression of inhibitory JNK mutants reduces UV-stimulated JNK activity. A, SHP-77 cells expressing epitope-tagged JNK1-APF and JNK2-APF were generated by retrovirus-mediated gene transfer. Cell extracts were submitted to SDS-PAGE and immunoblot analysis with the 12CA5 antibody. B, cell extracts were prepared from control and UV-irradiated (96 J/m2) SHP-77 transfectants, and JNK activity was assayed with the anti-JNK immune complex assay or with the GST-c-Jun binding assay as described under "Experimental Procedures." The data in panel B is the mean UV-stimulated JNK activity and S.E. (n = 3) presented as the percentage of the response observed in the LNCX controls. Inhibition of JNK activation by JNK1-APF and JNK2-APF was statistically significant, p < 0.05.
[View Larger Version of this Image (32K GIF file)]


Having demonstrated that the JNK-APF constructs are expressed and that they reduce UV-stimulated JNK activity, we investigated the influence of these molecular reagents on induction of SCLC apoptosis by UV. Fig. 7 shows that SHP-77 cells expressing the JNK1-APF construct were more resistant to UV-induced cell death compared with the LNCX control cells over a range of UV intensities. By contrast, no significant protection or sensitization to UV-irradiation resulted from expression of HA-JNK2-APF. The inset (Fig. 7) shows the average percent cell survival of the indicated SHP-77 transfectants following a 36 J/m2 UV exposure. At this UV intensity, the JNK1-APF cells were ~3-fold more resistant to UV-induced apoptosis. Thus, the findings indicate that expression of JNK1-APF inhibits the activation of specific JNK isoforms that are involved in UV-induced SCLC apoptosis.


Fig. 7. Expression of JNK1-APF, but not JNK2-APF, inhibits UV-induced apoptosis. Suspensions of LNCX- (open circle ), JNK1-APF- (square ), and JNK2-APF- (triangle ) expressing SHP-77 cells were exposed to the indicated doses of UV and then cultured for 3 days, and viable cells were counted. The inset shows mean percent survival and S.E. (n = 3) of the indicated cells irradiated at 36 J/m2 relative to nonirradiated cells.
[View Larger Version of this Image (36K GIF file)]



DISCUSSION

The present study demonstrates that UV irradiation of human SCLC cell lines induces an apoptotic response where several classic SCLC lines were significantly more sensitive to UV-induced cell death than variant SCLC lines that are frequently derived from relapsed SCLC tumors. These findings are consistent with previous reports that classic SCLC lines are more sensitive to cell killing by ionizing radiation than are variant SCLC lines (2, 4). The varied sensitivities of the SCLC lines to both UV and ionizing radiation could be explained by enhanced activity of cytoprotective pathways or reduced functioning of pathways that signal cell death. Manipulation of cellular glutathione levels is known to influence the sensitivity of cells to UV and ionizing radiation (41) and thus represents a potential cytoprotective pathway. However, no consistent differences have been observed in the cellular content of glutathione or glutathione-metabolizing enzyme activities in classic and variant SCLC (42). A wealth of information has recently highlighted the p53 protein as an important modulator of apoptosis in many cancers (5) where loss of functional p53 may increase the threshold of tumor cells to entry into apoptosis. Significantly, a study (43) has demonstrated that the p53 gene was mutated in 100% of SCLC lines and 80% of primary SCLC tumors, indicating that p53 status is not related to the differential sensitivity of variant and classic SCLC to UV and ionizing radiation. Likewise, expression levels of the Myc family members can influence the apoptotic response of tumor cells (5). However, amplification of N-myc and c-myc has been noted in H69 and N417 cells, respectively. Yet, H69 is significantly more UV-sensitive than N417 cells (Fig. 1B). Our observations point toward distinct JNK pathways in SCLC as a mechanism for variable resistance to UV-induced apoptosis. We hypothesize that a GST-c-Jun-binding JNK activity that correlates closely with the resistance of the individual SCLC lines to UV-induced cell death regulates a UV-protective program, while the JNK activity or activities that are disrupted by expression of JNK1-APF signal an apoptotic program. Thus, the overall sensitivity of the various SCLC lines to UV may be dictated by the summation or integration of cell-death and cell-protective programs, which are regulated by distinct JNK pathways.

We observed that expression of an inactivatable JNK1 mutant (JNK1-APF) reduced UV-stimulated JNK activity (Fig. 6) and induction of apoptosis (Fig. 7), indicating the involvement of a JNK1-like enzyme in a UV-stimulated pathway that promotes SCLC apoptosis. The involvement of JNKs and the related p38 MAP kinases has been previously invoked in the induction of apoptosis (29, 30). Acute withdrawal of nerve growth factor from PC12 cells that had previously been differentiated with this factor induces apoptosis in a fraction of the cells. Expression of catalytically inactive forms of MAP kinase/ERK kinase kinase, MAP kinase kinase 3, or MAP kinase kinase 4 or dominant-negative c-Jun significantly reduced apoptosis induced by nerve growth factor withdrawal in this system (30). Likewise, expression of dominant-negative c-Jun or catalytically inactive MAP kinase kinase 4 inhibited apoptosis in U937 monoblastic leukemia cells in response to a host of cytotoxic stimuli, including x-rays and UV-C radiation (29). Together, these studies indicate that stress-induced apoptosis requires a functional JNK signaling cascade.

We also characterized a UV-stimulated, GST-c-Jun-associated JNK activity that correlated closely with the relative resistance of the SCLC lines to UV-induced apoptosis (Fig. 4A). Indeed, precedent exists to support a role for protein kinase pathways in cytoprotection. Pretreatment of a non-small cell lung cancer line with the protein kinase inhibitor, staurosporine, at concentrations that are not specific for protein kinase C, sensitized the cells to killing by ionizing radiation in a manner independent of the repair of double-stranded DNA breaks (44). Also, tyrosine kinase inhibitors significantly sensitized HeLa cells to UV irradiation (45). Clearly, the initiating signal in the UV response is not provided by damaged DNA (11) as the response proceeds in enucleated cells. Membrane-associated Ras proteins are involved in both yeast (16) and mammalian systems (11, 18), consistent with the notion that the UV response arises at the plasma membrane, not damaged DNA in the nucleus. Significantly, resistance of yeast to UV irradiation is correlated with Ras activity and functioning of Gcn4, a yeast homologue of c-Jun and ATF-2 (16). Finally, oncogene-transformed mammalian cells frequently exhibit increased resistance to UV and ionizing radiation compared with their untransformed counterparts (25, 26).

Our findings thus support the existence of distinct JNK isoforms in SCLC which can regulate respective protective and cell death-inducing pathways. While the ability of JNK1-APF to inhibit JNK activation and increase the resistance of the SCLC cells to apoptosis provides evidence for a cell death-promoting pathway, JNK2-APF similarly inhibited JNK activation, but did not influence UV-stimulated apoptosis of SHP-77 cells. Therefore, we do not have direct evidence for a JNK pathway involved in cytoprotection. We have observed, however, that SHP-77 cells expressing HA-JNK2-APF, but not JNK1-APF, are significantly more sensitive to induction of apoptosis2 in response to a novel substance P antagonist, [D-Arg1, D-Phe5, D-Trp7,9, Leu11]substance P, which has recently been shown to induce apoptosis in SCLC (46). Clearly, published findings indicate that the defined JNK isoforms are not functionally redundant despite being activated by many of the same stimuli including UV irradiation and TNF-alpha (32, 33). In the yeast, Saccharomyces cerevisiae, where the HOG1 MAP kinase is required for growth on hypertonic medium, expression of the JNK1 enzyme, but not JNK2 enzyme, restores the ability of yeast lacking HOG1 to grow on hypertonic medium (33). It is likely that divergent roles for highly homologous members of a MAP kinase family such as JNK1 and JNK2 are dictated in part by differential recognition and phosphorylation of cellular targets. In fact, by virtue of a unique peptide sequence within its catalytic domain, JNK2 exhibits a 25-fold higher affinity for the transcription factor substrate, c-Jun, relative to JNK1 in vitro, which translates to a selective ability of JNK2 to regulate a c-Jun-controlled promoter (32). Thus, clear definition of the role of the JNK signaling cascade in cell regulation demands analysis of the individual JNK gene products and their respective cellular targets.

Immunoblotting of the cellular proteins that were specifically adsorbed to GST-c-Jun revealed a 46-kDa JNK species that bound regardless of UV irradiation as well as a JNK species with a slower mobility on SDS-PAGE (~48 kDa) that appeared only in extracts from UV-irradiated cells and was largely adsorbed from the extract by GST-c-Jun (Fig. 5). The selective adsorption to GST-c-Jun of an activated JNK species with a decreased mobility has been previously reported (47). It is unlikely that this JNK activity represents JNK1 or JNK2, since these protein kinases do not exhibit enhanced binding to GST-c-Jun when phosphorylated and activated (32, 47). We are considering the possibility that the GST-c-Jun-associated JNK activity that correlates with increased UV resistance represents the JNK3 or SAPKbeta isoform. Human JNK3 as well as rodent SAPKbeta is reported to be most highly expressed in neural tissue (21, 22) and were, in fact, cloned from brain cDNA libraries (20-22). It is interesting to speculate that a JNK3/SAPKbeta isoform may be more highly expressed in SCLC, as this human tumor expresses neuroendocrine differentiation (1).

The JNKs and the related p38 MAP kinases are noted for their brisk regulation in response to a host of cellular stresses including UV and ionizing radiation, heat shock, hyperosmolarity, and cytotoxic drugs (17-19, 39, 48). Furthermore, these protein kinases are activated by tumor necrosis factor-alpha and interleukin-1 receptors (19, 39), receptor tyrosine kinases (19, 27), a growing number of G protein-coupled receptors (49, 50), GTPase-deficient forms of heterotrimeric G proteins (37, 51, 52), and the Ras and Rho families of low molecular weight G proteins (53, 54). While JNK activation observed in response to cell stresses is often accompanied by cell damage and cell death, thereby complicating clear dissection of the role for the JNK response, the regulation of the JNK pathway by growth factor receptors and heterotrimeric G proteins is, in many instances, associated with cellular transformation (52, 54) or differentiation (37), not cell death. It is important to note that cell stresses often selectively activate the JNK cascade with little or no activation of the parallel ERK MAP kinase pathway. In contrast, stimulation of the JNK pathway by receptor tyrosine kinases and G protein-coupled receptors is accompanied by robust activation of the ERKs. Indeed, coordinate activation of the ERKs with the JNKs or p38 MAP kinases is associated with protection against apoptosis (30, 55). Thus, the function of the JNKs in a particular cellular context will likely depend not only on the cell type and its state of growth control, but also on additional signaling pathways that are coordinately activated.

In conclusion, the findings of this study are supportive of a role for distinct JNK pathways in signaling protective and apoptotic events in SCLC following UV radiation-induced cell damage. Enhanced activation of a JNK pathway that may promote protection against radiation-induced damage represents a potentially novel mechanism for conferring resistance to a variety of cytotoxic cell stresses. Molecular approaches leading to overexpression of dominant inhibitory forms of upstream regulatory protein kinases and downstream JNK targets coupled with pharmacologic inhibitors of the involved protein kinases as they become available will permit a definitive assignment for the role of the JNK pathway in the SCLC response to UV and ionizing radiation.


FOOTNOTES

*   This study was supported by National Institutes of Health Grants CA 58157, DK 19928, and GM 48826.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Division of Renal Medicine, C-281, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262. Tel.: 303-315-6065; Fax: 303-315-4852; E-mail: Lynn.Heasley{at}UCHSC.edu.
1   The abbreviations used are: SCLC, small cell lung cancer; MAP, mitogen-activated protein; JNK, c-Jun NH2-terminal kinase; SAPK, stress-activated protein kinase; ERK, extracellular signal-regulated kinase; HA, hemagglutinin; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; GST, glutathione S-transferase.
2   L. E. Heasley and L. Butterfield, unpublished observation.

ACKNOWLEDGEMENT

We appreciate the assistance of Nancy L. Johnson (National Jewish Center for Immunology and Respiratory Medicine, Denver, CO) for determination of SCLC apoptosis using the terminal deoxytransferase-based assay.


REFERENCES

  1. Carney, D. N., Gazdar, A. F., Bepler, G., Guccion, J. G., Marangos, P. J., Moody, T. W., Zweig, M. H., and Minna, J. D. (1985) Cancer Res. 45, 2913-2923 [Abstract]
  2. Carney, D. N., Mitchell, J. B., and Kinsella, T. J. (1983) Cancer Res. 43, 2806-2811 [Abstract]
  3. Carmichael, J., Mitchell, J. B., DeGraff, W. G., Gamson, J., Gazdar, A. F., Johnson, B. E., Glatstein, E., and Minna, J. D. (1985) Br. J. Cancer 57, 540-547
  4. Carmichael, J., DeGraff, W. G., Gamson, J., Russo, D., Gazdar, A. F., Levitt, M. L., Minna, J. D., and Mitchell, J. B. (1989) Eur. J. Cancer Clin. Oncol. 25, 527-534 [Medline] [Order article via Infotrieve]
  5. Fisher, D. E. (1994) Cell 78, 539-542 [Medline] [Order article via Infotrieve]
  6. Gazdar, A. F., Carney, D. N., Nau, M. M., and Minna, J. D. (1985) Cancer Res. 45, 2924-2930 [Abstract]
  7. Johnson, B. E., Ihde, D. C., Makuch, R. W., Gazdar, A. F., Carney, D. N., Oie, H., Russell, E., Nau, M. M., and Minna, J. D. (1987) J. Clin. Invest. 79, 1629-1634 [Medline] [Order article via Infotrieve]
  8. Brennan, J., O'Connon, T., Makuch, R. W., Simmons, A. M., Russell, E., Linnoila, R. I., Phelps, R. M., Gazdar, A. F., Ihde, D. C., and Johnson, B. E. (1991) Cancer Res. 51, 1708-1712 [Abstract]
  9. Buscher, M., Rahmsdorf, H. J., Liftin, M., Karin, M., and Herrlich, P. (1988) Oncogene 3, 301-311 [Medline] [Order article via Infotrieve]
  10. Devary, Y., Gottlieb, R., Lau, L. F., and Karin, M. (1991) Mol. Cell. Biol. 11, 2804-2811 [Medline] [Order article via Infotrieve]
  11. Devary, Y., Rosette, C., DiDonato, J. A., and Karin, M. (1993) Science 261, 1442-1445 [Medline] [Order article via Infotrieve]
  12. Gupta, S., Campbell, D., Derijard, B., and Davis, R. J. (1995) Science 267, 389-393 [Medline] [Order article via Infotrieve]
  13. Livingstone, C., Patel, G., and Jones, N. (1995) EMBO J. 14, 1785-1797 [Abstract]
  14. van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlich, P., and Angel, P. (1995) EMBO J. 14, 1798-1811 [Abstract]
  15. Whitmarsh, A. J., Shore, P., Sharrocks, A. D., and Davis, R. J. (1995) Science 269, 403-407 [Medline] [Order article via Infotrieve]
  16. Engelberg, D., Klein, C., Martinetto, H., Struhl, K., and Karin, M. (1994) Cell 77, 381-390 [Medline] [Order article via Infotrieve]
  17. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993) Genes Dev. 7, 2135-2148 [Abstract]
  18. Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994) Cell 76, 1025-1037 [Medline] [Order article via Infotrieve]
  19. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. (1994) Nature 369, 156-160 [CrossRef][Medline] [Order article via Infotrieve]
  20. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanaugh, J., Sluss, H. K., Derijard, B., and Davis, R. J. (1996) EMBO J. 15, 2760-2770 [Abstract]
  21. Mohit, A. A., Martin, J. H., and Miller, C. A. (1995) Neuron 14, 67-78 [Medline] [Order article via Infotrieve]
  22. Kyriakis, J. M., Woodgett, J. R., and Avruch, J. (1995) Ann. N. Y. Acad. Sci. 766, 303-319 [Medline] [Order article via Infotrieve]
  23. Cano, E., and Mahadevan, L. C. (1995) Trends Biochem. Sci. 20, 117-122 [CrossRef][Medline] [Order article via Infotrieve]
  24. Derijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., and Davis, R. J. (1995) Science 267, 682-685 [Medline] [Order article via Infotrieve]
  25. Sklar, M. D. (1988) Science 239, 645-647 [Medline] [Order article via Infotrieve]
  26. Suzuki, K., Watanabe, M., and Miyoshi, J. (1992) Radiat. Res. 129, 157-162 [Medline] [Order article via Infotrieve]
  27. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R. J., Johnson, G. L., and Karin, M. (1994) Science 266, 1719-1723 [Medline] [Order article via Infotrieve]
  28. Johnson, N. L., Gardner, A. M., Diener, K. M., Lange-Carter, C. A., Gleavy, J., Jarpe, M. B., Minden, A., Karin, M., Zon, L. I., and Johnson, G. L. (1996) J. Biol. Chem. 271, 3229-3237 [Abstract/Free Full Text]
  29. Verheij, M., Bose, R., Lin, X.-H., Yar, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. (1996) Nature 380, 75-79 [CrossRef][Medline] [Order article via Infotrieve]
  30. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995) Science 270, 1326-1331 [Abstract]
  31. Abdel-Hafiz, H., A.-M., Heasley, L. E., Kyriakis, J. M., Avruch, J., Kroll, D. J., Johnson, G. L., and Hoeffler, J. P. (1992) Mol. Endocrinol. 6, 2079-2089 [Abstract]
  32. Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Derijard, B., Moore, G., Davis, R., and Karin, M. (1994) Genes Dev. 8, 2996-3007 [Abstract]
  33. Sluss, H. K., Barrett, T., Derijard, B., and Davis, R. J. (1994) Mol. Cell. Biol. 14, 8376-8384 [Abstract]
  34. Miller, A. D., and Rosman, G. J. (1989) BioTechniques 7, 980-990 [Medline] [Order article via Infotrieve]
  35. Landau, N. R., and Littman, D. R. (1992) J. Virol. 66, 5110-5113 [Abstract]
  36. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993) Proc. Natl. Acad. U. S. A. 90, 8392-8396 [Abstract/Free Full Text]
  37. Heasley, L. E., Storey, B., Fanger, G. R., Zamarripa, J., and Maue, R. A. (1996) Mol. Cell. Biol. 16, 648-656 [Abstract]
  38. Kroemer, G., Petit, P., Zamzami, N., Vayssiere, J.-L., and Mignotte, B. (1995) FASEB J. 9, 1277-1287 [Abstract/Free Full Text]
  39. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Hau, J., Ulevitch, R. J., and Davis, R. J. (1995) J. Biol. Chem. 270, 7420-7426 [Abstract/Free Full Text]
  40. Xie, W., and Herschman, H. R. (1995) J. Biol. Chem. 270, 27622-27628 [Abstract/Free Full Text]
  41. Jensen, G. L., and Meister, A. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 4714-4718 [Abstract]
  42. Carmichael, J., Mitchell, J. B., Friedman, N., Gazdar, A. F., and Russo, A. (1988) Br. J. Cancer 58, 437-440 [Medline] [Order article via Infotrieve]
  43. D'Amico, D., Carbone, D., Mitsudome, T., Nau, M., Fedorko, J., Russell, E., Johnson, B., Buchlagen, D., Bodner, S., Phelps, R., Gazdar, A., and Minna, J. D. (1992) Oncogene 7, 339-346 [Medline] [Order article via Infotrieve]
  44. Kim, C. Y., Giaccia, A. J., Strulovici, B., and Brown, J. M. (1992) Br. J. Cancer 66, 844-849 [Medline] [Order article via Infotrieve]
  45. Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. (1992) Cell 71, 1081-1091 [Medline] [Order article via Infotrieve]
  46. Reeve, J. G., and Blechen, N. M. (1994) Biochem. Biophys. Res. Commun. 199, 1313-1319 [CrossRef][Medline] [Order article via Infotrieve]
  47. Dai, T., Rubie, E., Franklin, C. C., Kraft, A., Gillespie, D. A. F., Avruch, J., Kyriakis, J. M., and Woodgett, J. R. (1995) Oncogene 10, 849-855 [Medline] [Order article via Infotrieve]
  48. Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., and Kufe, D. W. (1995) Nature 376, 785-788 [CrossRef][Medline] [Order article via Infotrieve]
  49. Mitchell, F. A., Russell, M., and Johnson, G. L. (1995) Biochem. J. 309, 381-384 [Medline] [Order article via Infotrieve]
  50. Coso, O. A., Chiariello, M., Kalinec, G., Kyriakis, J. M., Woodgett, J., and Gutkind, J. S. (1995) J. Biol. Chem. 270, 5620-5624 [Abstract/Free Full Text]
  51. Heasley, L. E., Zamarripa, J., Storey, B., Helfrich, B., Mitchell, F. M., Bunn, P. A., Jr., and Johnson, G. L. (1996) J. Biol. Chem. 271, 349-354 [Abstract/Free Full Text]
  52. Prasad, M. V. V. S. V., Dermott, J. M., Heasley, L. E., Johnson, G. L., and Dhanasekaran, N. (1995) J. Biol. Chem. 270, 18655-18659 [Abstract/Free Full Text]
  53. Coso, O. A., Chiariello, M., Yu, J.-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. (1995) Cell 81, 1137-1146 [Medline] [Order article via Infotrieve]
  54. Minden, A., Lin, A., Claret, F.-X., Abo, A., and Karin, M. (1995) Cell 81, 1147-1157 [Medline] [Order article via Infotrieve]
  55. Gardner, A. M., and Johnson, G. L. (1996) J. Biol. Chem. 271, 14560-14566 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.